Table 3.

Selection criteria devised according to clinical findings and current guidelines by the ESC and AHA/ACC/HRS [15].

	Description
A	S-ICD used in inherited channelopathies and idiopathic ventricular fibrillation only
B	+ hypertrophic cardiomyopathy and grown-up congenital heart disease patients
C	+ primary and secondary prevention (for ventricular fibrillation only) of SCD in patients with QRS 150 ms. Approach C reflects current ESC and AHA/ACC/HRS

ESC, European Society of Cardiology; AHA, American Heart Association; ACC, American College of Cardiology; HRS, Heart Rhythm Society; S-ICD, Subcutaneous-Implantable Defibrillator; SCD, Sudden Cardiac Death.